Conway Erin L, Sellick John A, Kurtzhalts Kari, Mergenhagen Kari A
Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
University of Buffalo School of Medicine Infectious Diseases Department, Buffalo, New York, USA.
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02389-16. Print 2017 Mar.
The purpose of this study was to evaluate risk factors for failure of antibiotic treatment within 30 days for uncomplicated skin infections of outpatients treated in a Veterans Affairs hospital. A retrospective chart review of outpatients between January 2006 and July 2015 with an ICD-9 (International Statistical Classification of Diseases and Related Health Problems) code of cellulitis or abscess was included in the analysis. The primary outcome was success versus failure of the antibiotic, with failure defined as another antibiotic prescribed or hospitalization within 30 days for the original indication. A total of 293 patients were included in the final analysis, 24% of whom failed within 30 days. Obesity/overweight (body mass index [BMI] of >25 kg/m) was identified in 83% of the overall population, with 16% of that population having a BMI greater than 40 kg/m An elevated mean BMI of 34.2 kg/m ( = 0.0098) was found in the subset of patients who failed oral antibiotics compared to a BMI of 31.32 kg/m in patients who were treated successfully. Additionally, the patients who failed had an increased prevalence of heart failure at 16% ( = 0.027). Using multivariate logistic regression, BMI and heart failure were determined to be significant predictors of antibiotic prescription failure. Each 10-kg/m unit increase in BMI was associated with a 1.62-fold-greater odds of failure. A diagnosis of heart failure increased the odds of failure by 2.6-fold (range, 1.1- to 5.8-fold). Outpatients with uncomplicated skin infections with an elevated BMI and heart failure were found to have increased odds of failure, defined as hospitalization or additional antibiotics within 30 days.
本研究的目的是评估在退伍军人事务医院接受治疗的门诊患者单纯性皮肤感染30天内抗生素治疗失败的风险因素。分析纳入了2006年1月至2015年7月期间门诊患者的回顾性病历,这些患者的ICD - 9(国际疾病及相关健康问题统计分类)编码为蜂窝织炎或脓肿。主要结局是抗生素治疗成功与失败,失败定义为因原适应症在30天内开具另一种抗生素或住院治疗。最终分析共纳入293例患者,其中24%在30天内治疗失败。总体人群中83%被确定为肥胖/超重(体重指数[BMI]>25kg/m²),其中16%的人群BMI大于40kg/m²。与治疗成功的患者BMI为31.32kg/m²相比,口服抗生素治疗失败的患者亚组平均BMI升高至34.2kg/m²(P = 0.0098)。此外,治疗失败的患者心力衰竭患病率增加至16%(P = 0.027)。使用多因素逻辑回归分析,BMI和心力衰竭被确定为抗生素处方失败的显著预测因素。BMI每增加10kg/m²,失败几率增加1.62倍。心力衰竭诊断使失败几率增加2.6倍(范围为1.1至5.8倍)。发现BMI升高且患有心力衰竭的门诊单纯性皮肤感染患者失败几率增加,失败定义为30天内住院或使用额外抗生素。